We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCE
4926
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$735K ﹤0.01%
33,886
-93,573
-73% -$2.43M
VTOL icon
4927
Bristow Group
VTOL
$1.34B
$734K ﹤0.01%
23,055
-2,820
-11% -$82.3K
DS
4928
DELISTED
Drive Shack Inc.
DS
$734K ﹤0.01%
261,108
-1,466,609
-85% -$3.95M
ETWO.WS
4929
CALL
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$733K ﹤0.01%
252,620
+7,265
+3% +$21.8K
BBIG
4930
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$733K ﹤0.01%
+8,405
New +$566K
HTPA.U
4931
DELISTED
Highland Transcend Partners I Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
HTPA.U
$732K ﹤0.01%
70,000
-180,000
-72% -$1.82M
ARQT icon
4932
Arcutis Biotherapeutics
ARQT
$3.36B
$731K ﹤0.01%
+30,618
New +$698K
OKE icon
4933
CALL
Oneok
OKE
$57.2B
$731K ﹤0.01%
+12,600
New +$677K
SNEX icon
4934
StoneX
SNEX
$9.26B
$729K ﹤0.01%
55,991
+18,427
+49% +$237K
SMED
4935
DELISTED
Sharps Compliance Corp
SMED
$729K ﹤0.01%
88,154
-53,203
-38% -$495K
MGI
4936
DELISTED
MoneyGram International, Inc. New
MGI
$728K ﹤0.01%
90,828
-319,245
-78% -$3.04M
USNA icon
4937
Usana Health Sciences
USNA
$408M
$727K ﹤0.01%
7,887
-3,238
-29% -$312K
LGTY
4938
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$727K ﹤0.01%
30,626
+20,352
+198% +$469K
TARA icon
4939
Protara Therapeutics
TARA
$220M
$726K ﹤0.01%
104,918
-24,462
-19% -$191K
TASK icon
4940
TaskUs
TASK
$556M
$726K ﹤0.01%
10,936
-215,411
-95% -$10.2M
CFB
4941
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$726K ﹤0.01%
55,818
-5,065
-8% -$67K
DDI
4942
DoubleDown Interactive
DDI
$574M
$725K ﹤0.01%
+41,145
New +$702K
GNCA
4943
DELISTED
Genocea Biosciences, Inc.
GNCA
$725K ﹤0.01%
377,345
+91,304
+32% +$180K
BRW
4944
Saba Capital Income & Opportunities Fund
BRW
$336M
$724K ﹤0.01%
79,535
-202,650
-72% -$1.86M
XCUR icon
4945
Exicure
XCUR
$10.2M
$722K ﹤0.01%
4,010
-2,273
-36% -$461K
SWBK
4946
CALL
DELISTED
Switchback II Corporation
SWBK
$722K ﹤0.01%
523,392
+1,605
+0.3% +$15.9K
RBAC.U
4947
CALL
DELISTED
RedBall Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one
RBAC.U
$721K ﹤0.01%
896,632
+102,968
+13% +$1.04M
HBNC icon
4948
Horizon Bancorp
HBNC
$1.04B
$720K ﹤0.01%
39,620
+20,770
+110% +$359K
FACA.U
4949
DELISTED
Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
FACA.U
$720K ﹤0.01%
74,900
-43,588
-37% -$440K
VYGR icon
4950
Voyager Therapeutics
VYGR
$183M
$719K ﹤0.01%
273,360
-244,502
-47% -$794K

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.